Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Dermal macrophages might help regrow hair.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Special cells can help regrow hair in alopecia areata.

Hair graying may help prevent cancer by protecting stem cells.

Alopecia is caused by various factors, and new treatments like gene editing and regenerative medicine offer hope for personalized hair regrowth solutions.

The treatment using a special hydrogel shows promise for promoting hair growth.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Rabies vaccine might cause hair loss due to immune issues.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Interleukin-15 can help hair growth and protect hair follicles.

Hairless HRS/J mice resist Bacillus anthracis skin infections due to high numbers of immune cells, not because they lack hair follicles.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Alopecia areata involves immune response and gene changes affecting hair loss.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.